Senior Director, Launch & Lifecycle Management Excellence, Cell Therapy Supply Chain

Senior Director, Launch & Lifecycle Management Excellence, Cell Therapy Supply Chain

Working with Us Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

The Senior Director, Cell Therapy Launch & Lifecycle Management Excellence leads the global strategy, governance, and execution oversight of Launch Excellence capabilities across the Cell Therapy portfolio. The role is responsible for defining and advancing the long-term launch excellence roadmap, ensuring seamless alignment across Product Development, Operations, Supply Chain, Regulatory, Quality, and Commercial organizations to enable successful product launches and lifecycle changes worldwide.

The role serves as the central point of integration between development, manufacturing, supply chain, and commercial organizations to ensure launch readiness, portfolio prioritization, resource alignment, risk management, and execution excellence across all Cell Therapy assets.

The Senior Director leads a team of Launch Excellence Managers & Professionals and establishes the operating model, governance, and digital capabilities necessary to support current and future portfolio growth while driving continuous improvement and responsible AI adoption.

Key Responsibilities:

Strategy & Enterprise Launch Governance

• Define and maintain the global Launch Excellence strategy across the Cell Therapy portfolio.
• Develop and execute a multi-year Launch Excellence capability roadmap focused on scalability, operational excellence, and future portfolio growth.
• Establish a single source of truth for all Cell Therapy launch and lifecycle initiatives.
• Lead launch governance processes, portfolio prioritization, and executive escalation frameworks.
• Define launch performance measures, KPIs, and portfolio health metrics to drive decision-making and continuous improvement.
• Promote responsible AI adoption and digital innovation to enhance launch planning, forecasting, risk management, and execution.

Portfolio Launch Planning & Execution

• Provide strategic oversight for all Cell Therapy launch and lifecycle management programs.
• Ensure launch readiness across product development, manufacturing, quality, regulatory, supply chain, and commercial organizations.
• Oversee launch scenario planning, portfolio sequencing, resource planning, and risk mitigation activities.
• Lead launch forecasting and supply readiness assessments to inform portfolio investment and business decisions.
• Establish processes to identify emerging risks, capacity constraints, and execution challenges across the launch portfolio.
• Ensure post-launch performance monitoring and capture lessons learned to drive future launch excellence.

Product Obsolescence Process & Execution Framework

• Develop and operationalize a Product Obsolescence Process & Execution Framework across the Cell Therapy portfolio to proactively manage product, market, material, and lifecycle discontinuation scenarios.
• Define governance, decision rights, stage gates, and escalation pathways for obsolescence planning, risk assessment, approval, and execution.
• Establish an end-to-end execution playbook covering inventory disposition, regulatory and quality dependencies, commercial alignment, and stakeholder communications.
• Partner with Product Development, Supply Chain, Manufacturing, Regulatory, Quality, Finance, and Commercial teams to identify obsolescence triggers, assess patient and business impact, and coordinate mitigation plans.
• Create standardized tools, templates, metrics, and executive reporting mechanisms to monitor obsolescence readiness, track execution progress, capture risks, and embed lessons learned into future lifecycle management practices.

Cross-Functional Leadership & Business Integration

• Serve as the primary interface between Cell Therapy Operations, Development, Supply Chain, Commercial, Regulatory, Quality, and Finance organizations for launch strategy and governance.
• Enable alignment across global and regional leadership teams regarding launch priorities, tradeoffs, timelines, and risk management.
• Influence enterprise decision-making through executive-level communication and presentation of launch risks, opportunities, and strategic recommendations.
• Partner with Commercial…